reports
Statement From MariMed CEO And President Jon Levine Regarding The Drug...
Statement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration’s Decision To Recategorize Cannabis To Schedule III NORWOOD, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- The following is a statement from Jon Levine, CEO and President of leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD). “The impending announcement of the DEA’s decision to recategorize cannabis from Schedule I to Schedule III under the Controlled Substances Act is historic. The positive impact this will have cannot be overstated. Our industry, the mi...
Moody's Ratings assigns Aa2 to Metro Sewer District of Greater Cincinn...
Moody's Ratings (Moody's) has assigned a Aa2 to Metropolitan Sewer District of Greater Cincinnati, OH's (MSD) Sewer System Revenue Bonds, 2024 Series A expected to be issued with an estimated par amount of $100 million and Sewer System Refunding Revenue Bonds, 2024 Series B (Forward Delivery), with...
Brookfield Reinsurance and AEL Announce Expected Closing Date for Broo...
WEST DES MOINES, Iowa--(BUSINESS WIRE)-- Brookfield Reinsurance (NYSE, TSX: BNRE) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced that the previously announced acquisition of AEL by Brookfield Reinsurance is expected to close following the close of market on May 2, 2024. About AEL At American Equity Investment Life Holding Company, our policyholders work with over 40,000 independent agents and advisors affiliated with independent market organizations (IMOs), banks and broker-dealers through our wholly-owned operating subsidiaries. Advisors and agents...
Hyliion Holdings Reports First-Quarter 2024 Financial Results
AUSTIN, Texas--(BUSINESS WIRE)-- (NYSE: HYLN) (“Hyliion”), a developer of sustainable electricity-producing technology, today reported its first-quarter 2024 financial results. Key Business Highlights Announced that H2 Energy Group has executed a letter of intent to purchase up to 10 KARNO generator units that will operate on hydrogen rich syngas produced from sustainable processes Announced partnership with BayoTech to introduce Hyliion and BayoTech’s innovative solutions to each other’s customers Reiterated plans to deliver initial KARNO generator units to customers in late 2024 ...
State Street to Participate in Bernstein’s 40th Annual Strategic Decis...
BOSTON--(BUSINESS WIRE)-- State Street Corporation (NYSE: STT) announced today that its Chairman and Chief Executive Officer, Ron O’Hanley, and Vice Chairman and Chief Financial Officer, Eric Aboaf, will participate in Bernstein’s 40th Annual Strategic Decisions Conference in New York, NY on Friday, May 31, 2024, at 9:00 am ET. An audio webcast of the event will be accessible on the home page of State Street’s Investor Relations website, . A recorded replay will be available on the Investor Relations website later that day, for approximately ninety days following the presentation. About St...
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Co...
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe Company to Conduct Educational Workshops and Tutorials at CYTO and AAI’s IMMUNOLOGY2024 FREMONT, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CTKB), a leading cell analysis solutions company, continues its commitment to advancing the cell analysis market by actively participating in key industry gatherings worldwide. The company's Full Spectrum Profiling™ (FSP™) technology, designed for streamlining workflows, expediting discoveries, and enhancing efficiency, will be p...
Anoto publishes its annual report for 2023 and corrects for changes in...
Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report Stockholm, 30 April 2024 - Anoto Group AB (publ) (“Anoto”) today publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report published on 29 February 2024. The annual report is available on the Company’s website, Compared to previously communicated results in the year-end report for 2023, Anoto reports a change in the results in the annual report. The corrections on the consolidated results stemmed from updates made to th...
Anoto publicerar sin årsredovisning för 2023 och korrigerar för föränd...
Anoto publicerar sin årsredovisning för 2023 och korrigerar för förändringar i resultatet som redovisats i bokslutskommunikén Stockholm den 30 april 2024 - Anoto Group AB (publ) (”Anoto”) publicerar idag sin årsredovisning för 2023 och korrigerar för förändringar i resultatet som redovisats i bokslutskommunikén som publicerades den 29 februari 2024. Årsredovisningen finns tillgänglig på bolagets hemsida, Jämfört med tidigare kommunicerade resultat i bokslutskommunikén för 2023 redovisar Anoto en förändring av resultatet i årsredovisningen. Korrigeringarna av koncernens resultat är föranle...
Emergent BioSolutions Announces Amendment to its Existing Credit Facil...
Emergent BioSolutions Announces Amendment to its Existing Credit Facility GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and Seventh Amendment” to its existing credit facility. “In light of this amendment, Emergent now has an extended runway to execute on our go-forward business plan to stabilize our financial position,” stated Joe Papa, president and CEO of Emergent. “Our bank group continues to work with our management team in a constructive fashion, evidenced by this positive developmen...
Valerio Therapeutics annonce ses résultats financiers 2023 et fait le ...
PARIS--(BUSINESS WIRE)-- Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris : ALVIO), ci-après « Valerio Therapeutics » ou « la Société », société de biotechnologie au stade clinique spécialisée dans le développement de médicaments innovants ciblant les mécanismes de réponse aux dommages de l’ADN tumoral (DDR) et les oncogènes pilotes, publie aujourd'hui ses résultats consolidés pour l'exercice clos le 31 décembre 2023. Dr. Shefali Agarwal, Présidente Directrice Générale, declare : « J'ai le plaisir d'annoncer que le premier patient a été traité avec VIO-01 dans le cadre de ...
Ponce Financial Group, Inc. Reports First Quarter 2024 Results
Ponce Financial Group, Inc. Reports First Quarter 2024 Results NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Ponce Financial Group, Inc., (the “Company”) (NASDAQ: PDLB), the holding company for Ponce Bank (the “Bank”), today announced results for the first quarter of 2024. First Quarter 2024 Highlights (Compared to Prior Periods): Net income of $2.4 million, or $0.11 per diluted share for the three months ended March 31, 2024, as compared to net income of $0.5 million, or $0.02 per diluted share for the three months ended December 31, 2023 and net income of $0.3 million, or $0.01 per dil...
Completion of Second Tranche of Tenaris Share Buyback Program. Weekly ...
Completion of Second Tranche of Tenaris Share Buyback Program. Weekly Report (Monday, April 29, 2024) LUXEMBOURG, April 30, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) announced today the completion of the second tranche of its previously announced Share Buyback Program. During the second tranche, which ran from February 26, 2024, to (and including) April 29, 2024, the Company purchased a total of 16,367,003 ordinary shares for a total consideration of €277,137,521, or US$300 million. On April 29, 2024, the Company purchased the following o...
Finalización del Segundo Tramo del Programa de Recompra de Acciones de...
Finalización del Segundo Tramo del Programa de Recompra de Acciones de Tenaris. Reporte Semanal (Lunes, 29 de abril de 2024) LUXEMBURGO, April 30, 2024 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) anunció hoy la finalización del segundo tramo de su Programa de Recompra de Acciones previamente anunciado. Durante el segundo tramo, que se desarrolló desde el 26 de febrero de 2024, hasta el 29 de abril de 2024 (inclusive), la Compañía adquirió un total de 16,367,003 acciones ordinarias por una contraprestación total de €277,137,521, o US$300 millones....
Moody's Ratings assigns definitive ratings to J.P. Morgan Mortgage Tru...
Moody's Ratings (Moody's) has assigned definitive ratings to 33 classes of residential mortgage-backed securities (RMBS) issued by J.P. Morgan Mortgage Trust 2024-4, and sponsored by J.P. Morgan Mortgage Acquisition Corp. (JPMMAC). The securities are backed by a pool of prime jumbo (80.9% by balan...
United States Lime & Minerals Reports First Quarter 2024 Results and D...
United States Lime & Minerals Reports First Quarter 2024 Results and Declares Regular Quarterly Cash Dividend DALLAS, April 30, 2024 (GLOBE NEWSWIRE) -- United States Lime & Minerals, Inc. (NASDAQ: USLM) today reported first quarter 2024 results: The Company’s revenues in the first quarter 2024 were $71.7 million, compared to $66.8 million in the first quarter 2023, an increase of $4.9 million, or 7.4%. Lime and limestone revenues were $71.5 million in the first quarter 2024, compared to $66.5 million in the first quarter 2023, an increase of $4.9 million, or 7.4%. The increase in revenue...
Allied Announces First-Quarter Results
Allied Announces First-Quarter Results TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- Allied Properties Real Estate Investment Trust ("Allied") (TSX: "AP.UN") today announced results for the three months ended March 31, 2024. Results In the first quarter, Allied’s operating income from continuing operations was $78 million, up 2% from the comparable quarter last year. Allied’s net loss and comprehensive loss was $19 million, in large part due to a fair value loss on investment properties flowing from declines in development-property valuations in Toronto, Edmonton and Montréal ($31 million...
Moody's Ratings assigns provisional ratings to six CMBS classes of BX ...
Moody's Ratings (Moody's) has assigned provisional ratings to six classes of CMBS securities, issued by BX Commercial Mortgage Trust 2024-MDHS, Commercial Mortgage Pass-Through Certificates, Series 2024 – MDHS: Cl. A, Assigned (P)Aaa (sf) Cl. B, Assigned (P)Aa2 (sf) Cl. C, Assigned (P)A3 (sf) C...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.